Exabis Library
Welcome to the e-CCO Library!
37: Outcomes from the 2015 Fellowships – Part 1: Selective histone deacetylase inhibitors: A potential new treatment of Inflammatory Bowel Diseases
2016
ECCO'16 Amsterdam
1
38: Outcomes from the 2015 Fellowships – Part 2: Sphingosine 1-phosphate (S1P)/S1PR3 axis a novel therapeutic target for intestinal fibrosis in Crohn’s Disease
2016
ECCO'16 Amsterdam
1
3: Abstract 1: Improvement of experimental mouse models in Inflammatory Bowel Diseases using flexible video endoscopic colon evaluation
2016
2nd Y-ECCO Basic Science Workshop
1
3: How to optimise recruitment to clinical trials in IBD
2016
1st School for Clinical Trialists
Wednesday, 15 March 2017, 4:30 PM by Vesna Babaja
1
3: IBD: The role of the exposome
2016
14th IBD Intensive Advanced Course
Friday, 16 April 2021, 2:11 PM by ECCO Administrator
1
3: Personalising Paediatric IBD: Identification of high and low risk patients at diagnosis
2016
3rd P-ECCO Educational Course
1
3: Session 2: Patient reported outcomes measures. New data
2016
2nd Advanced ECCO: EduCational COurse for Industry
1
40: Best abstract: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate to severe Ulcerative Colitis: Results from two phase 3 randomised controlled trials
2016
ECCO'16 Amsterdam
1
41: Best abstract: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s Disease: Interim analysis from the phase 2 FITZROY study
2016
ECCO'16 Amsterdam
1